Bloomage BioTechnology Corporation Company Description

Bloomage BioTechnology Corporation Limited researchers, develops, produces, and sells bioactive materials.

It offers pharmaceutical grade sodium hyaluronate which can be used as an API or excipient for drugs and medical devices in ophthalmic preparations, intra-articular injections, anti-adhesive preparations, and topical preparations for wound healing and soft tissue filler under the Hyature name; and cosmetic grade sodium hyaluronate solutions for cosmetic products, including moisturizing, repairing, delay skin aging, and brightening under the Hybloom, miniHA, microHA, Hyacross, Hyacolor, and cationHA.

The company also provides food-grade sodium hyaluronate for use in food/healthy food/dietary supplements under the HAPLEX name, as well as food-grade gamma aminobutyric acid under the Gabarelax name; hyaluronic acid for oral care under the Biomoist name; and animal care products under the HYAPET names.

Bloomage BioTechnology Corporation Limited was founded in 2000 and is headquartered in Jinan, the People’s Republic of China.

Bloomage BioTechnology Corporation Limited

Country	Cayman Islands
Founded	2000
Industry	Specialty Chemicals
Sector	Materials
Employees	4,655
CEO	Yan Zhao

Contact Details

Address: Tech Development Zone Jinan, 250101 China
Phone	86 531 8268 5998
Website	bloomagebioactive.com

Stock Details

Ticker Symbol	688363
Exchange	Shanghai Stock Exchange
Fiscal Year	January - December
Reporting Currency	CNY
ISIN Number	CNE100003NL9
SIC Code	2833

Key Executives

Name	Position
Yan Zhao	Chairman and GM
Jiajun Guo	Deputy GM and Director
Xueping Guo	Deputy GM of Core Technician and Director
Yizheng Li	Deputy GM, Secretary of the Board of Directors and Director
Aihua Liu	Deputy General Manager
Guixin Xu	Deputy General Manager
Gao Yi	Deputy General Manager
Luan Yizheng	Deputy General Manager
Hui Wang	Chief Financial Officer and Financial Director
Tao Tian	Head of Accounting and Accounting Supervisor